FSANZ Initiates Review of Young Child Formula Definitions and Labelling

FSANZ Commences P1066 Review of Young Child Formulas

Food Standards Australia New Zealand (FSANZ) has officially launched Proposal P1066, a critical review focusing on 'young child formula' products. This category, often marketed as toddler milk or junior milk, is now under the regulatory microscope, with FSANZ aiming to ensure these supplements adequately meet the nutritional requirements of young children whilst empowering parents with unambiguous product information.

For manufacturers like us, this signals a significant regulatory shift. A comprehensive re-evaluation of definitions, formulation guidelines, labelling standards, and overall product presentation will undoubtedly impact how these products are brought to market. The primary objective articulated by FSANZ is to ensure these formulas effectively support young children needing dietary supplementation and that consumers receive transparent, relevant information to make informed purchasing decisions.

Implications for Product Development and Compliance

From a formulation standpoint, brand owners currently operating in or considering entry into the Australian and New Zealand young child formula market must prepare for potential revisions to permitted ingredients, nutrient profiles, and even claim substantiation. The review's focus on nutritional adequacy suggests a closer look at the balance of macronutrients, micronutrients, and perhaps even novel ingredients commonly found in these products.

Beyond the formulation, the proposed changes to labelling and presentation are equally significant. Brands may face new requirements regarding front-of-pack claims, ingredient lists, allergy information, and even imagery used to market these products. For contract manufacturers, this means ensuring our clients' products remain fully compliant with evolving standards, from raw material sourcing through to final packaging. We anticipate increased demand for regulatory guidance and flexible manufacturing capabilities to adapt to potential specification changes.

"The FSANZ review underscores the continuous evolution of regulatory frameworks in the dietary supplement sector, particularly for sensitive demographics. Manufacturers must remain agile and proactive in their approach to compliance and innovation."

The regulatory landscape for specialist nutritional products is consistently tightening, reflecting a global trend towards consumer protection and stricter health claims. This FSANZ review serves as a timely reminder for all stakeholders involved in the production and distribution of young child formulas to review their current practices and prepare for what is shaping up to be a pivotal consultation phase.

Next Steps: Public Consultation Expected in 2026

FSANZ has indicated that public consultation on Proposal P1066 is slated for 2026. This period will offer a crucial opportunity for industry stakeholders, including manufacturers, ingredient suppliers, and consumer advocacy groups, to provide feedback and shape the final regulatory outcomes. Active participation in this process will be vital for mitigating potential disruptions and ensuring the industry's perspective is fully considered.

Brand owners should note that staying ahead of these changes will be key to maintaining market access and consumer trust. Engaging with manufacturing partners who possess extensive regulatory expertise will be invaluable during this transitional period.

Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.